Alexander-Miller M A, Leggatt G R, Berzofsky J A
Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1578, USA.
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4102-7. doi: 10.1073/pnas.93.9.4102.
The conventional approach to cytotoxic T-lymphocyte (CTL) induction uses maximal antigen concentration with the intent of eliciting more CTL. However, the efficacy of this approach has not been systematically explored with regard to the quality of the CTLs elicited or their in vivo functionality. Here, we show that a diametrically opposite approach elicits CTLs that are much more effective at clearing virus. CTLs specific for a defined peptide epitope were selectively expanded with various concentrations of peptide antigen. CTLs generated with exceedingly low-dose peptide lysed targets sensitized with > 100-fold less peptide than CTLs generated with high-dose peptide. Differences in expression of T-cell antigen receptors or a number of other accessory molecules did not account for the functional differences. Further, high-avidity CTLs adoptively transferred into severe combined immunodeficient mice were 100- to 1000-fold more effective at viral clearance than the low-avidity CTLs, despite the fact that all CTL lines lysed virus-infected targets in vitro. Thus, the quality of CTLs is as important as the quantity of CTLs for adoptive immunotherapy, and the ability to kill virally infected targets in vitro is not predictive of in vivo efficacy, whereas the determinant density requirement described here is predictive. Application of these principles may be critical in developing effective adoptive cellular immunotherapy for viral infections and cancer.
传统的细胞毒性T淋巴细胞(CTL)诱导方法使用最大抗原浓度,旨在引发更多的CTL。然而,就所引发的CTL的质量或其体内功能而言,这种方法的有效性尚未得到系统的探索。在此,我们表明一种截然不同的方法能引发在清除病毒方面更有效的CTL。针对特定肽表位的CTL用不同浓度的肽抗原进行选择性扩增。用极低剂量肽产生的CTL裂解用比高剂量肽产生的CTL少100倍以上肽致敏的靶细胞。T细胞抗原受体或许多其他辅助分子表达的差异并不能解释功能上的差异。此外,尽管所有CTL系在体外都能裂解病毒感染的靶细胞,但将高亲和力的CTL过继转移到严重联合免疫缺陷小鼠体内,在病毒清除方面比低亲和力的CTL有效100至1000倍。因此,对于过继免疫疗法而言,CTL的质量与CTL的数量同样重要,并且在体外杀死病毒感染靶细胞的能力并不能预测体内疗效,而此处描述的决定簇密度要求是可以预测的。这些原则的应用对于开发针对病毒感染和癌症的有效过继细胞免疫疗法可能至关重要。